A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratory-based polysomnography for the diagnosis and …
CL Rosen, D Auckley, R Benca, N Foldvary-Schaefer… - Sleep, 2012 - academic.oup.com
Sleep, 2012•academic.oup.com
Abstract Study Objectives: To test the utility of an integrated clinical pathway for obstructive
sleep apnea (OSA) diagnosis and continuous positive airway pressure (CPAP) treatment
using portable monitoring devices. Design: Randomized, open-label, parallel group,
unblinded, multicenter clinical trial comparing home-based, unattended portable monitoring
for diagnosis and autotitrating CPAP (autoPAP) compared with in-laboratory
polysomnography (PSG) and CPAP titration. Setting: Seven American Academy of Sleep …
sleep apnea (OSA) diagnosis and continuous positive airway pressure (CPAP) treatment
using portable monitoring devices. Design: Randomized, open-label, parallel group,
unblinded, multicenter clinical trial comparing home-based, unattended portable monitoring
for diagnosis and autotitrating CPAP (autoPAP) compared with in-laboratory
polysomnography (PSG) and CPAP titration. Setting: Seven American Academy of Sleep …
Study Objectives
To test the utility of an integrated clinical pathway for obstructive sleep apnea (OSA) diagnosis and continuous positive airway pressure (CPAP) treatment using portable monitoring devices.
Design
Randomized, open-label, parallel group, unblinded, multicenter clinical trial comparing home-based, unattended portable monitoring for diagnosis and autotitrating CPAP (autoPAP) compared with in-laboratory polysomnography (PSG) and CPAP titration.
Setting
Seven American Academy of Sleep Medicine (AASM) accredited sleep centers.
Participants
Consecutive new referrals, age 18 yr or older with high probability of moderate to severe OSA (apnea-hypopnea index [AHI] = 15) identified by clinical algorithm and Epworth Sleepiness Scale (ESS) score = 12.
Interventions
Home-based level 3 testing followed by 1 wk of autoPAP with a fixed pressure CPAP prescription based on the 90% pressure from autotitration of PAP therapy (autoPAP) device (HOME) compared with attended, in-laboratory studies (LAB).
Measurements
CPAP acceptance, time to treatment, adherence at 1 and 3 mo; changes in ESS, and functional outcomes.
Results
Of 373 participants, approximately one-half in each study arm remained eligible (AHI > 15) to continue in the study. At 3 mo, PAP usage (nightly time at pressure) was 1 hr greater: 4.7 ± 2.1 hr (HOME) compared with 3.7 ± 2.4 hr (LAB). Adherence (percentage of night used > 4 hr) was 12.6% higher: 62.8 ± 29.2% compared with 49.4 ± 36.1% in the HOME versus LAB. Acceptance of PAP therapy, titration pressures, effective titrations, time to treatment, and ESS score change did not differ between arms.
Conclusions
A home-based strategy for diagnosis and treatment compared with in-laboratory PSG was not inferior in terms of acceptance, adherence, time to treatment, and functional improvements.
Oxford University Press